BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 36098472)

  • 1. Population-based meta-analysis and gene-set enrichment identifies FXR/RXR pathway as common to fatty liver disease and serum lipids.
    Handelman SK; Puentes YM; Kuppa A; Chen Y; Du X; Feitosa MF; Palmer ND; Speliotes EK
    Hepatol Commun; 2022 Nov; 6(11):3120-3131. PubMed ID: 36098472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The nuclear receptor FXR, but not LXR, up-regulates bile acid transporter expression in non-alcoholic fatty liver disease.
    Aguilar-Olivos NE; Carrillo-Córdova D; Oria-Hernández J; Sánchez-Valle V; Ponciano-Rodríguez G; Ramírez-Jaramillo M; Chablé-Montero F; Chávez-Tapia NC; Uribe M; Méndez-Sánchez N
    Ann Hepatol; 2015; 14(4):487-93. PubMed ID: 26019035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATP-binding cassette transporter G5 and G8 polymorphisms and several environmental factors with serum lipid levels.
    Li Q; Yin RX; Wei XL; Yan TT; Aung LH; Wu DF; Wu JZ; Lin WX; Liu CW; Pan SL
    PLoS One; 2012; 7(5):e37972. PubMed ID: 22655090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic activation of hepatic farnesoid X receptor prevents parenteral nutrition-associated cholestasis in mice.
    El Kasmi KC; Ghosh S; Anderson AL; Devereaux MW; Balasubramaniyan N; D'Alessandro A; Orlicky DJ; Suchy FJ; Shearn CT; Sokol RJ
    Hepatology; 2022 Feb; 75(2):252-265. PubMed ID: 34387888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Inflammatory Factors in Mediating the Effect of Lipids on Nonalcoholic Fatty Liver Disease: A Two-Step, Multivariable Mendelian Randomization Study.
    Chen J; Zhou H; Jin H; Liu K
    Nutrients; 2022 Oct; 14(20):. PubMed ID: 36297117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new perspective on NAFLD: Focusing on the crosstalk between peroxisome proliferator-activated receptor alpha (PPARα) and farnesoid X receptor (FXR).
    Zhou S; You H; Qiu S; Yu D; Bai Y; He J; Cao H; Che Q; Guo J; Su Z
    Biomed Pharmacother; 2022 Oct; 154():113577. PubMed ID: 35988420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bile salt excretory pump: biology and pathobiology.
    Suchy FJ; Ananthanarayanan M
    J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S10-6. PubMed ID: 16819395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of SNVs in ABCA1, ABCG1, ABCG5, ABCG8, and SCARB1 Genes on Plasma Lipids, Lipoproteins, and Adiposity Markers in a Brazilian Population.
    Zago VHS; Scherrer DZ; Parra ES; Vieira IC; Marson FAL; de Faria EC
    Biochem Genet; 2022 Apr; 60(2):822-841. PubMed ID: 34505223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triglycerides and gallstone formation.
    Smelt AH
    Clin Chim Acta; 2010 Nov; 411(21-22):1625-31. PubMed ID: 20699090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
    Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
    Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic ABCG5/G8 overexpression reduces apoB-lipoproteins and atherosclerosis when cholesterol absorption is inhibited.
    Basso F; Freeman LA; Ko C; Joyce C; Amar MJ; Shamburek RD; Tansey T; Thomas F; Wu J; Paigen B; Remaley AT; Santamarina-Fojo S; Brewer HB
    J Lipid Res; 2007 Jan; 48(1):114-26. PubMed ID: 17060690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ménage à trois of autophagy, lipid droplets and liver disease.
    Filali-Mouncef Y; Hunter C; Roccio F; Zagkou S; Dupont N; Primard C; Proikas-Cezanne T; Reggiori F
    Autophagy; 2022 Jan; 18(1):50-72. PubMed ID: 33794741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Messenger RNA levels of genes involved in dysregulation of postprandial lipoproteins in type 2 diabetes: the role of Niemann-Pick C1-like 1, ATP-binding cassette, transporters G5 and G8, and of microsomal triglyceride transfer protein.
    Lally S; Tan CY; Owens D; Tomkin GH
    Diabetologia; 2006 May; 49(5):1008-16. PubMed ID: 16518588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal CREBH overexpression prevents high-cholesterol diet-induced hypercholesterolemia by reducing
    Kikuchi T; Orihara K; Oikawa F; Han SI; Kuba M; Okuda K; Satoh A; Osaki Y; Takeuchi Y; Aita Y; Matsuzaka T; Iwasaki H; Yatoh S; Sekiya M; Yahagi N; Suzuki H; Sone H; Nakagawa Y; Yamada N; Shimano H
    Mol Metab; 2016 Nov; 5(11):1092-1102. PubMed ID: 27818935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiatherosclerotic effect of farnesoid X receptor.
    Mencarelli A; Renga B; Distrutti E; Fiorucci S
    Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H272-81. PubMed ID: 19028791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NF-κB Regulation of LRH-1 and ABCG5/8 Potentiates Phytosterol Role in the Pathogenesis of Parenteral Nutrition-Associated Cholestasis.
    Ghosh S; Devereaux MW; Anderson AL; Gehrke S; Reisz JA; D'Alessandro A; Orlicky DJ; Lovell M; El Kasmi KC; Shearn CT; Sokol RJ
    Hepatology; 2021 Dec; 74(6):3284-3300. PubMed ID: 34310734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Sleeve Gastrectomy on Nonalcoholic Fatty Liver Disease in an Obese Rat Model.
    Watanabe K; Ohta M; Takayama H; Tada K; Shitomi Y; Kawasaki T; Kawano Y; Endo Y; Iwashita Y; Inomata M
    Obes Surg; 2018 Jun; 28(6):1532-1539. PubMed ID: 29280057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation of hepatic farnesoid X receptor by FGF19 signaling-activated Src maintains cholesterol levels and protects from atherosclerosis.
    Byun S; Jung H; Chen J; Kim YC; Kim DH; Kong B; Guo G; Kemper B; Kemper JK
    J Biol Chem; 2019 May; 294(22):8732-8744. PubMed ID: 30996006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on LXR- and FXR-mediated effects on cholesterol homeostasis in normal and cholic acid-depleted mice.
    Wang J; Einarsson C; Murphy C; Parini P; Björkhem I; Gåfvels M; Eggertsen G
    J Lipid Res; 2006 Feb; 47(2):421-30. PubMed ID: 16264196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pravastatin activates the expression of farnesoid X receptor and liver X receptor alpha in Hep3B cells.
    Byun HW; Hong EM; Park SH; Koh DH; Choi MH; Jang HJ; Kae SH; Lee J
    Hepatobiliary Pancreat Dis Int; 2014 Feb; 13(1):65-73. PubMed ID: 24463082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.